Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination

At least six major steps are required for secreted thyroid hormone (TH) to exert its action on target tissues. Mutations interfering with three of these steps have been so far identified. The first recognized defect, which causes resistance to TH, involves the TH receptor β gene and has been given t...

Full description

Saved in:
Bibliographic Details
Published inBaillière's best practice & research. Clinical endocrinology & metabolism Vol. 21; no. 2; pp. 277 - 305
Main Authors Refetoff, Samuel, MD, Dumitrescu, Alexandra M., MD, PhD
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.06.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:At least six major steps are required for secreted thyroid hormone (TH) to exert its action on target tissues. Mutations interfering with three of these steps have been so far identified. The first recognized defect, which causes resistance to TH, involves the TH receptor β gene and has been given the acronym RTH. Occurring in ∼1 per 40,000 newborns, more than 1000 affected subjects, from 339 families, have been identified. The gene defect remains unknown in 15% of subjects with RTH. Two novel syndromes causing reduced sensitivity to TH were recently identified. One, producing severe psychomotor defects in > 100 males from 26 families, is caused by mutations in the cell-membrane transporter of TH, MCT8 ; the second, affecting the intracellular metabolism of TH in four individuals from two families, is caused by mutations in the SECISBP2 gene, which is required for the synthesis of selenoproteins, including TH deiodinases.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1521-690X
1878-1594
DOI:10.1016/j.beem.2007.03.005